There are 3397 resources available
Q&A
Presenter: All Speakers
Session: Proffered Paper session 2 - Genitourinary tumours, non-prostate
Resources:
Webcast
Q&A
Presenter: All Speakers
Session: Proffered paper session: Policy and preventive strategies
Resources:
Webcast
550O - Safety and efficacy of D-1553 in combination with cetuximab in KRAS G12C mutated colorectal cancer (CRC): A phase II study
Presenter: Rui-Hua Xu
Session: Proffered Paper session 1 - Gastrointestinal tumours, lower digestive
Resources:
Abstract
Slides
Webcast
1690O - Impact of the SARS-CoV-2 outbreak on the initial clinical presentation of new solid cancer diagnoses: A systematic review and meta-analysis
Presenter: Simon Marty
Session: Proffered paper session: Policy and preventive strategies
Resources:
Abstract
Slides
Webcast
LBA51 - Unraveling relatlimab (RELA)-specific biology using biomarker analyses in patients with advanced melanoma treated with nivolumab (NIVO)+RELA or NIVO alone in RELATIVITY-047
Presenter: Evan Lipson
Session: Mini oral session - Melanoma and other skin tumours
Resources:
Abstract
Slides
Webcast
2O - PD-1 defines a distinct, functional, tissue-adapted state in V-delta-1+ T cells with implications for cancer immunotherapy
Presenter: Yin Wu
Session: Proffered Paper session 2 - Basic Science and Translational research
Resources:
Abstract
Slides
Webcast
LBA93 - EXTENTORCH: A randomized, phase III trial of toripalimab versus placebo, in combination with chemotherapy as a first-line therapy for patients with extensive stage small cell lung cancer (ES-SCLC)
Presenter: Ying Liu
Session: Mini oral session 1 - Non-metastatic NSCLC and other thoracic malignancies
Resources:
Abstract
Slides
Webcast
LBA97 - Olanzapine for the prevention of chemotherapy induced nausea vomiting in patients receiving moderately emetogenic chemotherapeutic (MEC) regimens: Results of a prospective triple blinded phase III multicentric study (OMEC)
Presenter: Vikas Ostwal
Session: Mini oral session - Supportive and palliative care
Resources:
Abstract
Slides
Webcast
1882O - RENOTORCH: Toripalimab combined with axitinib versus sunitinib in first-line treatment of advanced renal-cell carcinoma (RCC) - A randomized, open-label, phase III study
Presenter: Xinan Sheng
Session: Proffered Paper session 2 - Genitourinary tumours, non-prostate
Resources:
Abstract
Slides
Webcast
551O - Impact of baseline molecular alterations on the efficacy of tucatinib (TUC) plus trastuzumab (Tras) for HER2+, RAS WT metastatic CRC (mCRC) in MOUNTAINEER
Presenter: John Strickler
Session: Proffered Paper session 1 - Gastrointestinal tumours, lower digestive
Resources:
Abstract
Slides
Webcast